Actinium Pharma (ATNM) Stock Price, Quote, News & History

Comments

Actinium Pharmaceuticals Inc (ATNM) Stock Price, Quote, News & History

ATNMAMEX

Trade with Public

$1.20

N/A

At close: Mar 9, 5:00 PM EST

$1.20

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.18

Close

$1.20

Volume / Avg.

51.78K / 140.81K

Day Range

$1.17 - $1.22

52 Wk Range

1.02 - 2.41

Market Cap

$37.44M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

53

Short Interest

3.42%

Days to Cover

9.8

Recent Actinium Pharmaceuticals Inc News

Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge

Avi Kapoor

Dow Tumbles 950 Points; ISM Services PMI Surges In July

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-25.04M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

-217.00K

Free Cash Flow (TTM)

-25.04M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-25.26M

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$14.81M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

415.97

PB Ratio (TTM)

2.72

Earnings Yield % (TTM)

-92.50%

Earnings Yield % (FWD)

-74.17%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.44

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$9.00K

Total Cash

$53.39M

Debt to Equity

0.08

Issuance of Debt (TTM)

-$9.00K

Repayment of Debt (TTM)

-$9.00K

Key Statistics

Open

$1.18

Close

$1.20

Volume / Avg.

51.78K / 140.81K

Day Range

$1.17 - $1.22

52 Wk Range

1.02 - 2.41

Market Cap

$37.44M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

53

Short Interest

3.42%

Days to Cover

9.8

About

Sector

Health Care

Industry

Biotechnology

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to de...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Actinium Pharma (ATNM) stock?

A

You can purchase shares of Actinium Pharma (AMEX:ATNM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Actinium Pharma (ATNM) competitors?

A

Other companies in Actinium Pharma’s space includes: Outlook Therapeutics Inc (NASDAQ:OTLK), Estrella Immunopharma Inc (NASDAQ:ESLA), Aligos Therapeutics Inc (NASDAQ:ALGS), Atossa Therapeutics Inc (NASDAQ:ATOS) and Sensei Biotherapeutics Inc (NASDAQ:SNSE).

Q

What is the forecast, or price target, for Actinium Pharma (ATNM) stock?

A

Actinium Pharma has a consensus price target of $10.43.

Q

What is the current price for Actinium Pharma (ATNM)?

A

The stock price for Actinium Pharma (AMEX: ATNM) is $1.2 last updated March 9, 2026 at 6:30 PM EDT.

Q

Does Actinium Pharma (ATNM) pay a dividend?

A

There are no upcoming dividends for Actinium Pharma.

Q

When is Actinium Pharma (AMEX:ATNM) reporting earnings?

A

Actinium Pharma does not have any upcoming earnings scheduled.

Q

Is Actinium Pharma (ATNM) going to split?

A

There is no upcoming split for Actinium Pharma.

Q

What sector and industry does Actinium Pharma (ATNM) operate in?

A

Actinium Pharma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch

Outlook Therapeutics Inc

NASDAQ:OTLK

$0.42

-5.77%

Estrella Immunopharma Inc

NASDAQ:ESLA

$1.04

-7.69%

Aligos Therapeutics Inc

NASDAQ:ALGS

$6.30

-11.51%

Atossa Therapeutics Inc

NASDAQ:ATOS

$4.80

4.79%

Sensei Biotherapeutics Inc

NASDAQ:SNSE

$29.21

-0.99%

Palatin Technologies Inc

Lisata Therapeutics Inc

NASDAQ:LSTA

$5.02

-0.40%

Key Statistics

Open

$1.18

Close

$1.20

Volume / Avg.

51.78K / 140.81K

Day Range

$1.17 - $1.22

52 Wk Range

1.02 - 2.41

Market Cap

$37.44M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

53

Short Interest

3.42%

Days to Cover

9.8

Recent Actinium Pharmaceuticals Inc News

Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge

Avi Kapoor

Dow Tumbles 950 Points; ISM Services PMI Surges In July

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-25.04M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

-217.00K

Free Cash Flow (TTM)

-25.04M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-25.26M

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$14.81M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

415.97

PB Ratio (TTM)

2.72

Earnings Yield % (TTM)

-92.50%

Earnings Yield % (FWD)

-74.17%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.44

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$9.00K

Total Cash

$53.39M

Debt to Equity

0.08

Issuance of Debt (TTM)

-$9.00K

Repayment of Debt (TTM)

-$9.00K

Key Statistics

Open

$1.18

Close

$1.20

Volume / Avg.

51.78K / 140.81K

Day Range

$1.17 - $1.22

52 Wk Range

1.02 - 2.41

Market Cap

$37.44M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

53

Short Interest

3.42%

Days to Cover

9.8

About

Sector

Health Care

Industry

Biotechnology

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to de...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry